Navigation Links
Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare
Date:6/19/2009

3. The survey merely provided a snapshot of equipment use in 2005 among 80 providers.

MedPAC itself even cautioned against using its survey to determine equipment use rates. According to transcripts of an April 19, 2006 meeting, MedPAC said: "This survey is a first stepIt was not nationally representative and it was not designed to determine equipment use rates. Its intent was to assess the feasibility of getting use rate data from the survey." CMS also agreed that that MedPAC's survey was unsound. In its 2007 proposed physician rule, CMS did not alter the equipment utilization assumption, stating: "We do not believe we have sufficient empirical evidence to justify an alternative proposal [to the 50 percent utilization assumption.]"

According to a recent analysis conducted by The Moran Company, Medicare spending on advanced imaging specifically CT, MR, Nuclear Medicine and PET was reduced by 19.2 percent from 2006 to 2007 and volume of these services grew by a modest 1.9 percent, after imaging reimbursements were cut by the DRA. In fact, the survey shows that the rate of imaging volume growth has been declining since 2005. The slow 1.9 percent growth rate for advanced imaging is less than the overall growth rate for Medicare physician payments in general. For all imaging services, spending has decreased by 13.3 percent from 2006 to 2007. Additionally, the Moran analysis shows Medicare reimbursements for dual-energy x-ray absorptiometry (DXA), a key bone-mineral density screening test used to diagnose and monitor osteoporosis, fell by 40 percent from 2006 to 2007. The survey shows that reimbursement in 2007 fell to its lowest level since 2000. As deep Medicare spending cuts went into affect in 2006 and 2007, after the implementation of the DRA, the volume of DXA screenings declined by .2 percent. This marked the first time since Medicare began reimbursing physicians for DXA screenings that the volume of screening declined.


'/>"/>
Contact: Sarah Mills
smills@powelltate.com
202-585-2084
Powell Tate
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Data: Actual imaging use far below Presidents rec. 95 percent utilization rate for Medicare
2. Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
3. New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
4. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
5. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
6. Shining light on sciences dark data: New venture ensures a fuller scientific record
7. New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
8. Five Hospitals to Share Patient Data: ICW Connects Regional Medical Centers and University Facility
9. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
10. Perceived cancer risks may not reflect actual risks or prevention needs
11. Proposed E-Cigarette Ban Pushed in the Name of Americas Health Actually a Backdoor Boost to Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... yesterday by the Mental Health Commission of Canada ... and education that police personnel receive. , "People ... Canada,s police community, and today,s report builds on ... people with mental illnesses," says Queen,s adjunct professor ... in the area of police psychology. "This is ...
(Date:8/29/2014)... New York, New York (PRWEB) August 29, 2014 ... died from cardiac arrest following a series of dialysis ... that alleges her death was the result of ... Liebhard LLP reports. The family’s lawsuit, which was file ... 2014, claims that the use of the products resulted ...
(Date:8/29/2014)... A team of scientists from the University of Colorado ... a process to expand production of stem cells used ... that extend beyond cancer, including treatments for inborn immunodeficiency ... article published Aug. 29 in PLOS ONE ... Regenerative Medicine and Stem Cell Biology and Taiga Biotechnologies, ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... 2014 LiveOps, Inc., the global leader ... announced that LiveOps has been selected as a call ... of Strength Telethon for the third year in a ... awareness to support MDA’s mission to help children and ... fatal muscle disease. This year’s program includes performances by ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4
... , , SAN FRANCISCO, Sept. 22 ... will be a key driver of economic growth in the state over ... almost 1 million workers with a collective earning power of more than ... on whether California,s education system will be able to provide enough health ...
... Finding explains why obese children have higher relapse rates, ... Leukemia cells can hide in fat tissue to evade ... are more likely to develop chemotherapy resistance and have ... found that obese children with leukemia are 50 percent ...
... take into account side effects, researchers say , TUESDAY, ... advanced prostate cancer can increase the risk of heart ... be safer than others, new research has found. , ... advanced prostate cancer or prostate cancer that had spread ...
... Role of Innovation in Global Public Health , , ... Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and ... research can improve health care across the U.S. and around the world. ... M.D., founder of Biogen and a member of the Prix Galien USA ...
... 22 The Neuropathy Association has announced two awardees ... , Every year, The Neuropathy Association--the leading ... neuropathies--awards two scientific research grants, each for $80,000 over ... This year,s grant recipients--Dennis Paul, Ph.D. and co-principal investigator, ...
... , Surgeons Urge Prompt Treatment for Growth Plate ... and outdoors, youth athletes stay active year-round in competitive sports, and for many ... American College of Foot and Ankle Surgeons advises that when a child complains ... warning sign of a serious foot problem. , , ...
Cached Medicine News:Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 2Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 3Health News:Leukemia Cells May Hide in Fat Tissue 2Health News:Hormone Therapy for Prostate Cancer Raises Heart Risks 2Health News:Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech 2Health News:Neuropathy Association Research Grants Advance the Understanding of Diabetic Neuropathy and Autoimmune Neuropathies 2Health News:Heel Pain in Youth Athletes: A Warning Sign 2
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... April 14, 2011 Oxford Finance Corporation (Oxford), a ... a $2 million equipment loan with Synta Pharmaceuticals Corp. ... compounds for use in Synta,s ongoing clinical trials in ... "Synta Pharmaceuticals has a diverse drug pipeline, including ...
... (NYSE: BT ) shared its vision of ... cloud computing strategies to pharma research at the Bio-IT ... This vision reflects BT,s strong capabilities and increasing specialization ... world,s leading pharmaceutical companies rely on BT to support ...
Cached Medicine Technology:Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp. 2BT Pushes for R&D Innovation at Bio-IT World Conference 2BT Pushes for R&D Innovation at Bio-IT World Conference 3
Futuremeds Astotherm Plus Blood and Fluid Warmers meet American Blood Bank and ECRI standards., ,Astotherm is a durable warmer you can rely on for many years....
... anesthesia solution for the MRI environment , ... ,The Narkomed MRI-2 is the only ... monitor, designed and engineered to perform, without distance ... environments of up to 3.0 Tesla. This feature ...
... Narkomed GS provides high quality ventilation ... The proven technologies of the AV2+ ... the Narkomed GS user-friendly and intuitive. ... quality Narkomed GS is the perfect ...
... facilities where space is a premium Fabius ... delivery technologies with an ergonomic and compact ... of the Draeger Infinity patient monitoring range ... environment that is a sound investment into ...
Medicine Products: